Top 5 Best Practices for Clinical Disclosure SOPs
MAY 21, 2018 Clinical trial disclosure requirements are growing globally with regulations in over 90 countries and continuously evolving data sharing norms based on increasing
MAY 21, 2018 Clinical trial disclosure requirements are growing globally with regulations in over 90 countries and continuously evolving data sharing norms based on increasing
MARCH 15, 2018 Increasing demands for clinical trial disclosure and transparency are dominating the medical journals and making their way into more general news outlets
JANUARY 17, 2018 On January 18, 2018, results for applicable clinical trials (ACTs) with a primary completion date on or after January 2017 start becoming
AUGUST 1, 2017 A recent article in the British Medical Journal on Pharmaceutical companies’ policies on access to trial data, results and methods, is an interesting
JUNE 6, 2017 OVERVIEW: Regulatory Risk is the possibility that changing regulations will significantly affect the organization, requiring additional investments, changes in operations, or other adjustments
MAY 25, 2017 INTRODUCTION: Medical research funders like the Wellcome Trust, the Bill and Melinda Gates Foundation, and others are getting serious about clinical trial
MAY 12, 2017 The growing scope of global disclosure Global Disclosure Clinical trials are conducted in almost every country in the world, each with its
APRIL 18, 2017 Discussions with TrialScope customers and others have confirmed that challenges with global clinical trial disclosure are prevalent across organizations, regardless of size.
APRIL 17, 2017 April 18, 2017 is the date that your studies must comply with the Final Rule… are you ready? Tips to prepare for
Copyright © 2022 Pharma Intelligence UK Limited
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 – 12 St. James’s Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group